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Abstract
Malaria is endemic in India with an estimated 70-100 million cases each year (1.6-1.8 million
reported by NVBDCP); of this 50-55% are Plasmodium vivax and 45-50% Plasmodium falciparum. A
recent study on malaria in pregnancy reported from undivided Madhya Pradesh state (includes
Chhattisgarh state), that an estimated over 220,000 pregnant women contract malaria infection
each year. Malaria in pregnancy caused- abortions 34.5%; stillbirths 9%; and maternal deaths 0.45%.
Bulk of this tragic outcome can be averted by following the Roll Back Malaria/WHO
recommendations of the use of malaria prevention i.e. indoor residual spraying (IRS)/insecticide-
treated bed nets (ITN) preferably long-lasting treated bed nets (LLIN); intermittent preventive
therapy (IPT); early diagnosis, prompt and complete treatment using microscopic/malaria rapid
diagnostics test (RDT) and case management. High incidence in pregnancy has arisen because of
malaria surveillance lacking coverage, lack of age and sex wise data, staff shortages, and intermittent
preventive treatment (IPT) applicable in high transmission states/pockets is not included in the
national drug policy- an essential component of fighting malaria in pregnancy in African settings.
Inadequate surveillance and gross under-reporting has been highlighted time and again for over
three decades. As a result the huge problem of malaria in pregnancy reported occasionally by
researchers has remained hidden. Malaria in pregnancy may quicken severity in patients with drug
resistant parasites, anaemia, endemic poverty, and malnutrition. There is, therefore, urgent need
to streamline malaria control strategies to make a difference in tackling this grim scenario in human
health.
Background
A recent article on malaria in pregnancy (MiP) contrib-
uted by three prestigious organizations (Indian Council of
Medical Research, National Vector Borne Disease Control
Programme, World Health Organization), monitoring
malaria situation in India has revealed appalling situation
of pregnant women contracting malaria infection [1]. In
undivided Madhya Pradesh (Madhya Pradesh and Chhat-
tisgarh states of India), the estimated annual MiP was in
excess of 220,000 infections; 76,000 abortions; 19,800
stillbirths; and 1,000 maternal deaths. In the past, several
studies from India and other countries of the WHO's
South East Asia Region have highlighted the tragedy of
pregnant women living in malaria endemic regions [2].
Persistent neglect of MiP is widening the gender equity
gap of the already skewed gender picture emerging due to
social reasons [3]. It is noteworthy to mention that
malaria incidence data reported by the NVBDCP is grossly
under-reported, and this fact has been highlighted time
and again by several independent studies and the NVB-
DCP's in-depth evaluations [4-7]. Furthermore, NVB-
DCP's surveillance does not collect data on malaria in
pregnant women and children under five years of age
(U5), and, principally for this reason, malaria in preg-
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nancy has remained hidden [8]. Wherever and whenever
quality surveillance was undertaken it has exposed the
real picture of malaria. An account of the prevailing
malaria situation of pregnant women, neonates, and U5
in India, and countermeasures to make a difference in the
existing malaria situation in high-risk groups (pregnant
women and U5), are briefly described in the discussion
below.
Discussion
Malaria is endemic in India, distributed throughout the
length and breadth of the country, and an estimated
>90% population (2001 population 1.13 billion) is at risk
of the disease. Malaria surveillance is carried out at fort-
nightly intervals through a multi-purpose worker (MPWs)
scheme at the village level, the active case detection
(ACD). Blood film from fever cases are also collected at
the Primary Health Centres (PHCs) and malaria clinics,
called the passive case detection (PCD). In the last few
years other health workers (e.g. Angarwari and Accredited
Social Health Activist, ASHA) are also supplementing the
blood smear collection from fever cases. Thus, NVBDCP
collects about 100 million blood smears annually for <2
million parasite positive cases. ACD and PCD data is col-
lated at the district and state level (state NVBDCP) and
transmitted to NVBDCP for final compilation and deci-
sion-making. NVBDCP reported 1,785,109 parasite posi-
tive cases (9,44,741 Pv + 8,40,368 Pf) and 1,708 deaths in
2006. The 2007 data is still provisional [8]. The malaria
situation in the country has remained static with small
variations [8,9]. This unrealistic situation has arisen from
the surveillance system that has broken down, and per-
haps can only be relied on for malaria trends. Similarly
malaria deaths are poorly recorded as the definition of
death due to malaria require demonstration of malaria
parasite in the peripheral blood, which is an unattainable
goal in a highly diverse country with bulk of population
in rural areas (c75%). As a result malaria has remained a
huge problem in India with an estimated 90-160 million
cases and more than 120,000 deaths in SEA Region [10],
70% of these from India. Furthermore, the existing sur-
veillance system does not collect age and sex-wise data,
abortions and still-births, which is vital for evaluating the
impact of malaria in pregnancy [8]. Obviously, the prob-
lem of malaria in general and particularly in the high risk
groups (pregnant women and U5) has remained hidden,
although alarming as has been brought out by several
independent studies [11-13]. The tragedy of being born in
a poor and neglected settlements is revealed by the fact
that hospital based studies in Ispat General Hospital in
Rourkela, Orissa have revealed the rising trend of severity
and multi-organ failure in P. falciparum infections [14].
Although the precise reasons for this paradigm shift in
pathology is not understood, drug resistance may be an
important contributing factor. The cost of treatment in the
private sector and hospitalization is huge and unafforda-
ble [14] in a country with 26% population living below
poverty line (US cents c25/day) [15].
The distribution of malaria parasites viz., P. vivax, P. falci-
parum and Plasmodium malariae are highly uneven. Para-
site formula changes from place to place and season to
season, but can be interrupted by effective interventions.
In general, the proportion of P. vivax is about 50% and P.
falciparum around 40 to 45% for India; whereas P. malar-
iae cases may be in thousands in forested areas of Orissa
state (not recorded by the NVBDCP), and there is no focus
of  Plasmodium ovale and  Plasmodium knowlesi, so far
recorded [6,7]. Malaria in the north-eastern states is stable
and in many other states with high proportion of P. falci-
parum, malaria is nearly stable; whereas in the rest of India
it is unstable [16]. Malaria is entering towns and new ter-
ritories under development slowly but steadily, e.g. towns
in Orissa, Karnataka, Kerala etc. At present, rural malaria
accounts for >90-95% cases and urban malaria <5-10%
cases [17]. Low malaria incidence in urban areas is due to
almost non-existing surveillance. The data is collected
through the malaria clinics in hospitals. A retrospective
study of data collected from leading hospitals in Ahmeda-
bad revealed an average ratio of reported to estimated
malaria cases as 36,766/4,119, i.e. nine times more than
the reported rate, and 22 deaths per million population
[6]. Plasmodium falciparum incidence could be very high in
towns as for example, taken average of data between
1995-2000; Chennai represented 77% malaria cases and
61% of P. falciparum cases in Tamil Nadu state.
The strategic direction for controlling malaria in preg-
nancy has been well documented in several WHO publi-
cations. Pregnant women suffer from malaria on account
of their change in body physiology making them at least
twice as attractive to mosquitoes compared to non-preg-
nant women [18]. Any of the two parasites P. vivax or P.
falciparum, or both are potentially dangerous infections in
pregnancy and may produce fatal outcome to the mother
or may lead to still birth, abortion, low birth weight
(LBW) babies. In pregnancy, women have high propor-
tion of P. falciparum infection, which is a potentially fatal
disease [11-13,19,20]. There are compounding factors to
the already bad malaria situation, particularly in pregnant
women and their neonates. These are the mono- and
multi-drug resistance in P. falciparum [21,22], and now
reports of severe malaria in P. vivax cases [23], and chloro-
quine resistance in P. vivax [23]. Some anti-malarial drugs
are contraindicated in pregnancy and in U5, due to G6PD
deficiency e.g. primaquine, or artemisinin-based drugs
[24,25]. An estimated 370 million populations (c25%)
live below poverty line (BPL), and poverty worsen malaria
situation. Studies in India have revealed that states with
BPL population below national average of 26.1% haveMalaria Journal 2009, 8:281 http://www.malariajournal.com/content/8/1/281
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performed better in malaria control, than those with high
BPL population [15]. Severe malaria, which is more fre-
quent in MiP, requires hospitalization. Treatment cost of
severe malaria is invariably far beyond affordable means
of a common man, say USD 1,000 or more in private sec-
tor; and even in government hospitals (treatment is free),
the cost of medicines has to be borne by the patients [14].
According to the National Family Health Survey III (2005-
06), anaemia in India is alarmingly high. NFHS III
reported that 79.1% of India's children between the ages
of three and six, and 56.2% of married women in the age-
group 15-49 were anaemia in 2006 [26]. Malaria in the
background of endemic anaemia [27] could be a precipi-
tating factor for complications during pregnancy. An epi-
demic of malaria in Mewat (Haryana) in 1977 in the
background of endemic anaemia created chaos with pro-
tracted illness and deaths [28]. Plasmodium falciparum is
also the most predominant infection in the tribal areas. A
study in 1966 revealed that India's tribal population con-
stitutes 7.8%, and this population contributes India's
40% malaria and 60% P. falciparum annually. This was the
basis of a focused attack on the disease through World
Bank Assistance in 1,045 PHCs in 108 districts of the eight
states [29]. In addition to overall deteriorating malaria
trends, malaria epidemics visit two or three endemic states
annually. In epidemic situations, drug resistance strains
abound [29]. All these add up to a dismal picture of
malaria in pregnancy.
WHO recommends a three-pronged strategy that com-
prises: (i) intermittent preventive treatment (IPT) [30];
(ii) insecticide-treated nets, preferably long-lasting nets
(LLINs) [31]; and (iii) case management of malaria illness
[32]. Drug Policy of India, 2008 [26] is not aligned with
the evidence-based best practices recommended by the
Roll Back Malaria (RBM) initiative. IPT in pregnant
women is recommended by WHO as an important com-
ponent of RBM specifying epidemiological situations,
although such situations exist in India and in the other
countries of the South East Asia [30]. Most malaria deaths
in pregnancy occur at home or in the private sector. Hard
to reach, remote and difficult villages continue to suffer
intensely from neglect requiring further decentralization
of health care. Malaria prevention by indoor residual
spraying DDT (Dichlorodiphenyl trichloroethane),
Malathion and synthetic pyrethroids) has been almost
given up in the country except under special situations
[33]. NVBDCP is now focusing on insecticide-treated bed
nets (ITN). In 2002-2003, 60,000 ITN and 1.2 million
ITN in 2003-2004, were distributed in high malaria
endemic districts, and, in 2005-2008, 4.2 million ITN
were distributed in 10 states financed by the Global Fund
[9]. For example, in-depth review of NVBDCP based on
sampling of households revealed that ownership of bed
nets was low, e.g. in high malarious states with proportion
of households with at least one net and proportion with
at least one treated net was 31.5% and 20.7% in Mahar-
ashtra, 29.3% and 17.5% in Orissa and 42.6% and 0.4%
in Assam. Spray coverage of the target population varied
from 35-57%, but the quality of households with uniform
and complete coverage varied from 1.2 to 17.7% [33].
Table 1 gives the population under various categories as
classified by the NVBDCP. High-risk populations requir-
ing preventive malaria control represents 69 million, i.e.
5.78 million in NE and 63.22 million in EMCP states.
These numbers are huge and its coverage requires a more
realistic planning and mobilization of resources.
Unfortunately bed nets distributed till the middle of 2006
have already lost their usefulness and require replacement
Table 1: Malaria in India in 2007
States Population 
(2001 census in 
millions)
Malaria
Positives 
(% +s out of total)
Pregnant Women
In millions (2.9%)*
Children Under 5 
in millions
(12.1%)*
P. falciparum
Positives (%)
Malaria deaths
(% of total deaths)
NE States 38.49 (3.74%) 161,407 (10.9%) 1.12 4.66 120,871
(74.9% Pf)
494
(42.11%)
EMCP states 424.33 (41.32%) 990,575
(67.08%)
12.31 50.91 550,561
(55.58% Pf)
502
(42.79%)
Other states 462.82 (45.06%) 324,580
(21.98%)
13.42 56.00 65,417
(20.15% Pf)
177
(15.08%)
All India 1027 (100%) 1,476,562
(100%)
26.85 111.57 736,849
(49.9% Pf)
1173
(100%)
Census 2001 population data.
Enhanced Malaria Ccontrol Project (EMCP) states: Andhra Pradesh, Chhatisgarh, Gujarat, Jharkhand, Madhya Pradesh, Maharashtra, Orissa, 
Rajasthan
NE states: Arunachal Pradesh, Nagaland, Manipur, Mizoram, Tripura, Meghalaya, Assam.
*Based on WHO SEARO fact sheet [40].Malaria Journal 2009, 8:281 http://www.malariajournal.com/content/8/1/281
Page 4 of 5
(page number not for citation purposes)
as per the WHO norms (three-year life of nets) [30]. In
early diagnosis, prompt and complete treatment NVBDCP
is still depending on microscopic examination of blood
smears (in 2006, 106,606,707 blood smears were exam-
ined and 1,785,109 were found malaria positive), but in
Global Fund-financed districts malaria rapid diagnosis
test (RDT) have been introduced. Management of P. falci-
parum has become a formidable challenge particularly in
pregnancy [9]. High P. falciparum-states require priority
attention to combat malaria in pregnancy through time-
tested technologies recommended by WHO. Inertia
would impinge on the national commitment of Millen-
nium Development Goals (MDG) of halting the spread of
malaria and reversing the trend, and Maternal Mortality
Ratio (MMR), which is currently at 407 per 100,000 to
100 per 100,000 live births by 2015 [34]. Further, NVB-
DCP needs to keep up-to-date with new developments in
malaria control. These are the intermittent preventive
therapy for infants (IPTi) [35], rectal artesunate [36],
strengthening small hospitals [37], new drugs in pipe line
from Medicines for Malaria Venture (MMV)[38], and
developments in Integrated Vector Management [39].
Conclusion
Malaria in pregnancy has emerged as a major hidden pub-
lic health problem at the national level. The following
actions may be initiated for the management of malaria in
pregnancy. These are the (i) intensive campaign to reduce
anaemia on priority by up-scaling diagnosis and treat-
ment of illnesses, birth control, supplementation of nutri-
tion prioritizing areas with intense malaria transmission,
(ii) recognition of malaria in pregnancy as an important
health problem in India, its delimitation, stratification,
and realistic calculations for planning and interventions;
(iii) strengthening malaria surveillance and laboratory
services for reliable data collection, age and sex-wise dis-
tribution, and other fatal outcome, in time and space; (iv)
urgent need of scaling-up for impact of the preventive
methods; (v) review of national malaria drug policy to
include intermittent preventive therapy in pregnancy in
stratified regions, similar to African settings; (vi) adoption
of the RBM WHO recommendations on management of
malaria and its control in pregnancy; (vii) care of illness
in pregnancy; (viii) training of various categories of health
staff; (ix) timely procurement of supplies, distribution,
monitoring and evaluation; and (x) the programme
should keep abreast with the new emerging technologies
suitable for various epidemiological situations e.g. new
drugs and improved drug delivery.
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